Find Academic Supervisors

• Medical Biometry
• Epidemiology
• Cognitive Dysfunction
• +4 more

Insa Feinkohl is a Professor at the Chair of Medical Biometry and Epidemiology within the Faculty of Health at the University of Witten/Herdecke . Her research focuses on risk factors for cognitive dysfunction and mental health in older adults, particularly post-surgery, with emphasis on metabolic and cognitive risk factors. Bachelor of Science (BSc) in Psychology (1 st class honors) – University of Dundee (2006-2009) Master of Science (MSc) in Psychology of Individual Differences (with distinction) – University of Edinburgh (2009-2010) PhD in Community Health Sciences – University of Edinburgh (2010-2014) Post Doc in Knowledge Construction Group – Leibniz Institute for Knowledge Media, Tübingen (2014-2015) Postdoc in Molecular Epidemiology Group – Max Delbrück Center, Berlin (2015-2022) Habilitation in Molecular Epidemiology – Charité Universitätsmedizin Berlin (2021) Her research integrates medical biometry and epidemiology to study postoperative cognitive dysfunction (POCD), delirium, and aging-related cognitive decline. Key areas include biomarker validation (e.g., leptin, interleukins), brain connectivity (dopaminergic networks, thalamus), and metabolic risk factors (diabetes, obesity). She contributed to the BioCog project , an EU-funded initiative for personalized risk prediction of postoperative cognitive impairment. Her recent publications highlight trends in perioperative neuroscience, including brain mineralization, cytokine associations with neurocognitive disorders, and structural/functional imaging in delirium. Articles also explore metabolic syndrome, cognitive reserve, and delirium prediction models using machine learning. Insa Feinkohl is affiliated with major academic societies, including the German Society for Epidemiology , German Society for Medical Informatics, Biometry and Epidemiology , and the German University Association .

• Thrombosis
• Cardiovascular diseases
• Endothelial cell biology
• +7 more

Associate Professor Freda Passam is a Clinical Academic Haematologist at Royal Prince Alfred Hospital, University of Sydney, specializing in thrombosis and haemostasis. She leads the Haematology Research Group at the Charles Perkins Centre, focusing on platelet biology, endothelial cell dysfunction, and translational research in cardiovascular diseases. Her work integrates basic science with clinical applications, including developing microfluidic technologies like the Endo-chip for thrombosis diagnosis and therapy screening. Education: MD and PhD in Greece (angiogenesis in Hodgkin’s lymphoma), postdoctoral training at UNSW and Harvard University. Research spans platelet hyperactivity in diabetes, immune thrombosis (e.g., HIT), and thiol isomerase inhibitors as antithrombotics. Collaborates globally with institutions like Harvard and the University of Utah. Research Interests: 1) Platelet biomarkers in diabetes-related cardiovascular risk; 2) Immune thrombosis diagnostics/therapies (e.g., Endo-chip); 3) Bone marrow-on-chip models for thrombopoiesis. Current projects include SEC61B regulation of calcium flux, endothelial thromboinflammation, and ERp5/ERp57 roles in platelet production. Grants: Over $6M in funding from NHMRC, MRFF, NSW Health, and industry partnerships. Notable awards include Sydney Nano Grand Challenge Award (2022) and SLHD VTE Stewardship Award (2020). Advising: Mentors over 6 PhD/master’s students in thrombosis research, emphasizing clinical/research integration. Teaching includes Sydney Medicine curriculum, bedside tutorials, and student engagement in lab activities. Labs/Teams: Haematology Research Group (Charles Perkins Centre), collaborations with Sydney Health Partners, Harvard, and international haematology groups. Develops technologies like the Endo-chip and bone marrow-on-chip models.

Maria M. AlemanView profile

Assistant Professor

• Blood and vascular biology
• Erythropoiesis
• Iron metabolism
• +5 more

Maria M. Aleman, PhD is an Assistant Professor in the Department of Pharmacology at the University of North Carolina at Chapel Hill School of Medicine. Her research focuses on understanding fundamental mechanisms of erythropoiesis, blood and vascular biology, and the intersection of RNA regulation with iron metabolism in non-malignant hematology. Dr. Aleman's primary research interests center on erythropoiesis (red blood cell differentiation and maturation), investigating how hematopoietic stem cells differentiate through multiple stages until committing to the erythroid lineage. Her work particularly examines the family of dual functional proteins known as poly C binding proteins, which both regulate RNA processing and chaperone iron within cells. Using biochemical, cellular, and in vivo models, her laboratory explores the cross talk between iron trafficking and RNA regulation mediated by these proteins and how these activities are modulated by disease. Analysis of Dr. Aleman's publication record reveals a strong focus on hemostasis, thrombosis, and coagulation disorders, with significant contributions to understanding venous thrombosis mechanisms, factor VIII therapies for hemophilia A, and the role of various proteins in blood clotting processes. Her work bridges basic science with clinical applications, particularly in non-malignant blood disorders. Dr. Aleman maintains an active research laboratory (the Aleman Lab) at UNC Chapel Hill, where she investigates the basic mechanisms regulating erythropoiesis. Her work combines expertise in pharmacology, hematology, and molecular biology to address fundamental questions about blood cell formation and function. While specific grant information isn't detailed in the available materials, her consistent publication record across multiple high-impact journals suggests sustained research funding in her areas of expertise.

Laura AlmasyView profile

Professor

• Genetics
• Genomics
• Computational Biology
• +3 more

Laura Almasy serves as Professor of Genetics in the Department of Genetics at the University of Pennsylvania, with affiliations in the Genomics and Computational Biology Graduate Group. Her work bridges statistical genetics, neuroimaging, and complex trait analysis across psychiatric and cardiovascular domains. Her academic foundation includes a B.A. in Biology and Psychology from Swarthmore College (1990), followed by an M.Phil. (1992) and Ph.D. (1996) in Genetics from Yale University. Postdoctoral training was completed at the Southwest Foundation for Biomedical Research (1996-1998). Research centers on genetic architecture of complex diseases , integrating whole-genome sequencing , gene dosage studies , and neurocognitive phenotyping . Key emphases include schizophrenia risk mechanisms, cardiovascular remodeling in congenital heart disease, and population-specific genetic effects. Recent work leverages cross-ancestry genomic analyses and multimodal trait integration to dissect gene-environment interactions. Analysis of 2024-2025 publications reveals accelerating focus on copy-number variant impacts across cognitive and physiological traits, with growing attention to liver-related genetic regulation and personalized brain network mapping. Collaborative studies consistently incorporate large pedigree designs and transdisciplinary methodologies spanning psychiatry, cardiology, and computational biology. No details regarding scientific awards, student mentorship, grant funding, or laboratory teams were provided in the source material.

Kevin R. SiebenlistView profile

Academic

• Hemostasis
• Fibrinogen Structure and Function
• Thrombosis
• +3 more

Dr. Kevin R. Siebenlist is an Associate Professor Emeritus in the Department of Biomedical Sciences at Marquette University's College of Health Sciences. He holds a Ph.D. in Biochemistry from the Medical College of Wisconsin (1984) and completed postdoctoral training in hemostasis at The Blood Center of Southeastern Wisconsin and Sinai Samaritan Medical Center. His research focuses on hemostasis, particularly fibrinogen structure and function, factor XIII activity, and thrombin interactions. Education: B.S., Chemistry, University of Wisconsin-Milwaukee (1977) Ph.D., Biochemistry, Medical College of Wisconsin (1984) Postdoctoral Fellowships in Hemostasis (1984–1987) Research Interests: Dr. Siebenlist studies fibrinogen's role in blood clotting, including its structural variations (e.g., γ' chain function), factor XIII-mediated crosslinking, and thrombin binding dynamics. His work explores how these molecular interactions influence clot formation, stability, and thrombotic risks. Publications reflect contributions to understanding fibrinogen mutations (e.g., Fibrinogen Cedar Rapids), factor XIII activity, and fibrinolysis regulation. He has authored/co-authored over 50 peer-reviewed articles and abstracts, with recent work focusing on α2-antiplasmin incorporation into fibrinogen and Factor XIII variants' crosslinking activity. Scientific Awards/Honors: Phi Beta Kappa Phi Kappa Phi Member, American Association for the Advancement of Science Member, International Fibrinogen Research Society Member, 'Scientist Panel' of Index Copernicus International Teaching and Curriculum: Dr. Siebenlist teaches courses in biochemistry, organic chemistry for health sciences, and pre-medical/pre-dental advising. He contributes to programs like the Undergraduate Summer Research Program and the Pre-Dental Post-Baccalaureate Program. Lab Affiliations: Collaborates with the Fibrinogen Research Laboratory at The Blood Center of Southeastern Wisconsin (Dr. Mosesson) on in vitro fibrinogen expression systems and mutagenesis studies.

• Epidemiology
• Public Health
• Social Determinants of Health
• +5 more

Professor Michael Marmot is a leading epidemiologist at University College London (UCL) , where he serves as Director of the UCL Institute of Health Equity and holds the Professorship in Epidemiology & Public Health since 1985. He also holds the Bernard Lown Visiting Professorship at Harvard University and has contributed to global health policy through his advisory role with the WHO Director-General . His work focuses on social determinants of health inequalities and has resulted in influential reports like 'Closing the Gap in a Generation' (2008) and 'Fair Society, Healthy Lives' (2010). Doctor of Philosophy, University of California - Berkeley (1975) Master of Public Health, University of California - Berkeley (1972) Bachelor of Medicine/Bachelor of Surgery, University of Sydney (1968) Bachelor of Science (Honours), University of Sydney (1966) Marmot's research explores the social gradient in health , linking psychosocial stress to biological pathways like the metabolic syndrome and fibrinogen levels that increase cardiovascular risk. He investigates health impacts of deindustrialization , social isolation , and structural racism , with recent work addressing ageing populations , child-inclusive societies , and AI in healthcare . His studies span global contexts from Russia to Hong Kong and focus on health equity policy . His articles show trends in social determinants (2025), UK health equity reform (2024), child health interventions (2025), and housing as a health determinant (2025). These publications emphasize cross-sectoral policy and systemic inequality reduction . Recipient of the WHO Global Hero Award and Prince Mahidol Award for Public Health (2015) Honorary doctorates from 18 universities including Lund, Ghent, and Norwegian University of Science and Technology Advisory roles for WHO , British Government , and European Commission Marmot teaches modules on social epidemiology , mental health in global context , and health inequalities at UCL and NYU London. His work bridges academic research, policy implementation, and public health advocacy.

Xiao W. MaoView profile

Research Professor

• Radiation Medicine
• Space Medicine
• Ocular Biology
• +5 more

Xiao W. Mao, MD is a Research Professor at Loma Linda University School of Medicine with dual appointments in the Basic Sciences Biomedical Engineering Science Division and Radiation Medicine department. His primary research focuses on radiation-induced vascular damage in central nervous system tissues, particularly examining mitochondrial oxidative damage in the retina and brain following radiation exposure. Dr. Mao's research interests span Radiation Medicine , Space Medicine , Ocular Biology , and Neurovascular Remodeling . His work investigates how radiation and oxidative stress trigger microvascular and tissue remodeling, with special emphasis on spaceflight conditions' effects on brain, eye, and skin. He has pioneered research on antioxidant protectors for radiation damage, notably testing metalloporphyrin-based SOD mimetics as potential adjuncts to radiation therapy. Analysis of Dr. Mao's recent publications reveals a consistent focus on space radiation effects and microgravity impacts on ocular and neural systems. His research demonstrates how spaceflight conditions induce oxidative damage leading to mitochondrial apoptosis in retinal tissue, suggesting astronauts face increased risk for late retinal degeneration. His work combines radiation biology , ophthalmology , and space physiology to develop potential countermeasures for space-related health issues. Dr. Mao has secured substantial research funding as Principal Investigator for numerous NASA grants, including the Bion-M2 Spaceflight-induced Effects on Neurovascular Remodeling project (2020-2024) and Effects of Spaceflight on Ocular Oxidative Stress (2016-2021). His research team has participated in Space X-12 and Space X-24 missions, conducting in-orbit animal studies to evaluate retinal microvascular changes under space conditions. As an active member of the American Society of Gravitational and Space Research (2007-2019), Dr. Mao regularly presents at NASA Human Research Program Investigators' Workshops and Radiation Research Society meetings. His laboratory focuses on stereological quantification of microvessel damage following radiation exposure, using advanced imaging techniques to measure capillary length and structural changes in 3D microscopic data.

Moniek de MaatView profile

Professor

• Biochemistry of Haemostasis
• Thrombosis
• Fibrinogen Variants
• +7 more

Prof. Moniek de Maat is a leading researcher in the Biochemistry of Haemostasis and Thrombosis at the Erasmus University Medical Center (Rotterdam, Netherlands) and a Visiting Professor at the University Hospital of South West Denmark. Her work focuses on fibrinogen variants , fibrin network architecture , and their roles in thrombosis , stroke outcomes , and coagulation disorders . Education: PhD in Biochemistry (1995, Erasmus University), Chemistry (Biochemistry) at Utrecht University (1987-1991). Career: Senior researcher at TNO (1991-1999, 1999-2003), Associate Professor (2003-2018), and Professor (2018-present) at Erasmus MC, Head of Hemostasis Lab (2008-2023). Research Focus: Her work explores how genetic and protein variation in fibrinogen affects clot stability , fibrinolysis , and thrombosis risk . She investigates biomarkers for acute ischemic stroke and NETosis (neutrophil extracellular traps) in cardiovascular and infectious diseases like COVID-19 . Her team studies fibrin network properties under flow and in biofilms , aiming to optimize patient treatment. Publication Trends: Recent articles (2023-2025) highlight her expertise in fibrinogen variants , NETs , and stroke biomarkers , with collaborations in diabetes , COVID-19 coagulopathy , and biofilm-related thrombosis . Key journals include J Thromb Haemost , Acta Biomater , and TH Open . Scientific Awards: Outstanding Investigator Award, International Fibrinogen Research Society (2010) Advising: She mentors PhD students (Aarazo Barakzie, Hande Eyisoylu) and postdocs (Charlene Jacqmarcq), with alumni (Tirsa Koopman). Her lab collaborates with departments in epidemiology , cardiology , pediatric hematology , microbiology , and neurology across institutions like TU Delft and MUMC+ .

• Host-Pathogen Interactions
• Molecular Biology
• Microbiology
• +4 more

Emma-Jayne Proctor is an Associate Research Fellow/Lecturer at the University of Wollongong's School of Chemistry and Molecular Biosciences. She completed her Doctor of Philosophy (2016–2022) and Bachelor of Medical Biotechnology (2012–2015) at the same institution. Her research focuses on host-pathogen interactions, particularly involving Streptococcus pyogenes and protein interactions critical to bacterial virulence. She explores molecular mechanisms of bacterial pathogenesis, protein chaperoning, and therapeutic design using advanced techniques like mass photometry. Proctor has secured funding for projects targeting streptococcal exotoxins and developing peptide therapeutics. She currently supervises a PhD project investigating novel host-pathogen interactions in Streptococcus pyogenes M1 UK lineage. Research Interests: Streptococcal pathogenesis and virulence mechanisms Protein-protein interactions in host-pathogen systems Misfolded protein chaperoning and neurodegenerative disease Development of protein degradation therapies Funding Grants (2024): Targeting Streptococcal Exotoxins: Rational Design of Peptide Therapeutics Pilot Research (Early Mid-Career Enabling Grant) Teaching & Supervision: Involved in higher degree research supervision and contributes to molecular biosciences education at the university.

Muriel C. MaurerView profile

Professor

• Protein Chemistry
• Protein Structure-Function Relationships
• Blood Coagulation
• +4 more

Dr. Muriel C. Maurer is a Professor and Director of Graduate Studies in the Department of Chemistry at the University of Louisville. Her research focuses on protein chemistry, protein structure-function relationships, and blood coagulation, particularly investigating enzymes like Factor XIII, thrombin, and fibrinogen. She has held roles including Vice-Chair of the Chemistry Department and served as an Honorary Senior Research Fellow at the University of Leeds. Education: B.A. in Chemistry (Goucher College, 1987), Ph.D. in Chemistry (University of Virginia, 1993), followed by postdoctoral training at Cornell University. She joined the University of Louisville in 1997 and was promoted to Full Professor in 2008. Research interests include understanding the biochemical and biophysical mechanisms of coagulation proteins, with a focus on their roles in clot formation and regulation. Techniques used include biochemistry, mass spectrometry, NMR, and analytical ultracentrifugation. Her work aims to identify novel therapeutic strategies for clot-related disorders. Professional affiliations include the American Chemical Society, Biophysical Society, and the International Society of Thrombosis and Haemostasis. She has served on NIH study sections and editorial boards, including the Biophysical Chemistry Advisory Board and the Fibrinogen and Factor XIII Scientific Standardization Committee. Her research group includes graduate and undergraduate students, with recent projects exploring Factor XIII activation pathways, fibrinogen crosslinking, and thrombin exosite interactions. Collaborations have included institutions such as the University of Leeds and Cornell University.

Ashley BrownView profile

Associate Professor

• Biomaterials Engineering
• Regenerative Medicine
• Hemostasis
• +3 more

Ashley Brown is an Associate Professor and University Faculty Scholar in the Joint Department of Biomedical Engineering at North Carolina State University (NCSU) and the University of North Carolina at Chapel Hill (UNC). She leads the Brown Advanced Wound Healing Lab, focusing on developing microgel-based materials for hemostasis, wound healing, and regenerative medicine. Her research addresses translational challenges in trauma care, fibrosis, and infection control, with a particular emphasis on biomaterials engineering and cellular mechanotransduction. Education: Ph.D., Bioengineering, Georgia Institute of Technology (2011) B.S., Biosystems Engineering, Clemson University (2006) Research Interests: Microgel-based platelet-like particles (PLPs) for hemostasis Fibrin-cell interactions in wound repair Clot-targeted nanogels for thrombolytic therapy Biomaterials for infection control in wounds Awards & Recognitions: Biomaterials Science Emerging Investigator (2019) AIMBE Fellow and AHA Fellow (2023) NSF CAREER Award recipient Co-Director of the NCSU Comparative Medicine Institute Advising & Labs: Guides over 20 graduate and undergraduate students in interdisciplinary projects Lab collaborations span biomaterials, nanomedicine, and veterinary translational research Co-founded Selsym Biotech to commercialize hemostatic therapies Recent Trends in Publications: Focus on clot-targeted therapies, RNA-based anticoagulants, and bioprinted skin constructs. Over 50 peer-reviewed articles emphasize clinical translation and mechanistic insights into biomaterial-cell interactions.

• Bioactive (chromo)peptides from algae
• Protein-ligand interactions relevant for food systems
• Protein stability at high pressures
• +1 more

Simeon L. Minic serves as an Assistant Professor in the Department of Biochemistry at the Faculty of Chemistry, University of Belgrade, having progressed through academic ranks from Researcher-intern (2017) to his current position since 2023. His career trajectory reflects dedicated service within the same institution, including roles as Research Associate (2018-2021) and Senior Research Associate (2022). Dr. Minic completed all academic training at the University of Belgrade - Faculty of Chemistry: Basic Academic Studies in Chemical Sciences (2008-2012), Master of Academic Studies (2012-2013), and Doctorate in Chemical Sciences (2013-2017). His educational foundation underpins his specialized research in bioactive compounds from algae and protein interactions. His research program centers on bioactive chromopeptides from algae , protein-ligand interactions in food systems , protein stability under high pressure , and development of cell culture media . These interconnected themes drive innovation in sustainable food technologies, particularly for algae-based colorants, nutraceuticals, and cultured meat applications. His work bridges fundamental biochemistry with practical food science challenges. Analysis of his 15 most recent publications (2015-2022) reveals consistent focus on phycobiliproteins from algae (particularly phycocyanobilin) and their interactions with dairy proteins (β-lactoglobulin, serum albumin, α-lactalbumin). The research combines multi-spectroscopic techniques , molecular dynamics simulations , and functional property assessment to address stability, binding mechanisms, and applications in food coloring, fortification, and health. Emerging trends show increasing emphasis on sustainable food systems, including microplastic toxicity and cultured meat media development. Dr. Minic's scientific recognition includes: First place in Montenegro's republican chemistry competition (2008) Đorđe Stefanović Diploma as top biochemistry student (2013) University of Belgrade Student Award (2013) Serbian Chemical Society Annual Award (2013) FEBS scholarships for international research (2015, 2022) He teaches core biochemistry courses including Regulation of Biochemical Processes, Enzymology, and Biochemistry of Food and Nutrition. As principal investigator, he leads four major international projects: IMPTOX (Horizon 2020 microplastics study), PRESSION (algae protein fortification using high pressure), ALG2MEAT (algae extracts for cultured meat), and Pep4Meat (algae chromopeptides as serum replacement). These projects, funded by the European Commission, ANSO, Good Food Institute, and Serbian Science Fund, demonstrate significant research leadership. His laboratory work operates within the Department of Biochemistry at Belgrade's Faculty of Chemistry, collaborating with international consortia. Dr. Minic actively contributes to the Serbian Chemical Society, Biochemical Society of Serbia, and Serbian Proteomics Association, maintaining strong professional networks in food biochemistry and protein science.

Rehana LovelyView profile

Assistant Professor

• Molecular Biology
• Biochemistry
• Cardiovascular Disease
• +3 more

Rehana Lovely is an Assistant Professor at the Center for Anatomical Sciences within the College of Biomedical and Translational Sciences at UNT Health Fort Worth . She holds a Ph.D. from Yamagata University, Japan, and Master's and Bachelor's degrees from Dhaka University, Bangladesh. Education Ph.D., Yamagata University, Japan M.S., Dhaka University, Bangladesh B.S., Dhaka University, Bangladesh Her research focuses on the role of the gamma component of fibrinogen in blood clot formation, particularly how environmental and genetic factors influence fibrinogen-related cardiovascular diseases. She has developed assays for fibrinogen analysis, investigated dysfibrinogen mutations, and explored biomarkers for cardiovascular risk assessment. Analysis of her publications reveals key trends in Molecular Biology , Cardiovascular Research , and Hematology , with sub-fields spanning blood clotting mechanisms, protein structure-function relationships, and clinical diagnostics. Her work bridges basic science with translational applications in cardiovascular pathology. At UNT Health, she serves as course director for the Structural Anatomy course (SARS 5401) and teaches dissection-based anatomy to osteopathic medical students, prosection-based anatomy to physical therapy and physician assistant students, and participates in K-12 outreach programs to promote science and medicine careers.

Yvonne LeungView profile

Research Fellow

• Cognitive Psychology
• Neuroscience
• Dementia Research
• +7 more

Dr Yvonne Leung is a Postdoctoral Fellow at the School of Psychology, University of New South Wales (UNSW) . Her research focuses on cognitive ageing, dementia, and cognitive reserve , with expertise in harmonizing internationally sourced data and analyzing factors associated with cognitive impairment in ethno-regionally diverse populations. She was formerly the coordinator of the International Centenarian Consortium-Dementia and is currently funded by CEPAR to investigate gender differences in cognitive ageing and ageism . Education: PhD, The MARCS Institute for Brain, Behaviour and Development, Western Sydney University MA, University of Sheffield, UK BA(Hons), The MARCS Institute for Brain, Behaviour and Development, Western Sydney University BA, University of Queensland Research Interests include cognitive ageing, dementia, gender-specific cognitive resilience, and the impact of environmental and social factors on cognitive health. Her work bridges psychological health, data harmonization, and cross-cultural studies in older adults. Recent Publications span cognitive neuroscience, immunology, and music cognition. Key themes include environmental determinants of cognitive decline , gender differences in neurodegenerative diseases , music preference models , and antitumor immune responses . Scientific Awards: Kwan Fung and Yuet Ying Fung Healthy Brain Ageing Research Award (2018) Alzheimer's Association International Conference Travel Award (2018) The MARCS Institute Postgraduate Research Award (2013-2016) Western Sydney University Outstanding Academic Achievement (2009) Grants include funding from CEPAR for cognitive ageing studies. She has contributed to systematic reviews and meta-analyses of cognitive health in centenarians and near-centenarians.

Fraser MacraeView profile

Assistant Professor

• Wound healing
• Haemostasis
• Thrombosis
• +10 more

Dr Fraser Macrae is a University Academic Fellow and Sir Henry Wellcome Postdoctoral Fellow at the University of Leeds, working within the Faculty of Medicine and Health, School of Medicine, and the Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM). He leads research on the interplay between haemostasis, infection, and wound healing, with a specific focus on fibrin clot structure and function. Dr Macrae completed his undergraduate medical sciences degree (BSc hons) at the University of Leeds in 2011, followed by a part-time PhD while working as a research assistant in Professor Robert Ariëns' lab. His research has spanned over a decade, initially focusing on fibrin clots in cardiovascular disease before expanding to explore connections between coagulation, thrombosis, and wound healing. In 2019, he was awarded a Sir Henry Wellcome Fellowship to explore fibrin films in infection and wound healing. Research Focus Dr Macrae's primary research investigates how changes in coagulation link thrombosis and tissue repair. His work examines how alterations in clot formation contribute to thrombotic diseases (heart attacks, strokes, DVT) and investigates potential blood-related connections between thrombosis development and poor wound healing. His laboratory also explores cryopreservation of blood and its cells, addressing the growing clinical challenge of poor wound healing in chronic diseases. Professional Recognition Sir Henry Wellcome Fellowship from the Wellcome Trust (2019) Fellow of the Higher Education Academy (FHEA) Teaching and Leadership Dr Macrae actively teaches the undergraduate medical curriculum at Leeds, focusing on haemostasis, thrombosis, and wound healing. He contributes to the British Heart Foundation-funded 4-year PhD program and supervises undergraduate and postgraduate research students. As LICAMM lead for Mid-career development, he supports professional growth of researchers within the institute. Professional Affiliations International Society on Thrombosis and Haemostasis British Society for Haemostasis and Thrombosis Platelet Society Society of Low Temperature Biology